Quilt Health, Inc.

Quilt Health, Inc. is a Boston-based digital health company focused on improving care for individuals with complex conditions, particularly sickle cell disease, through innovative technology and data-driven insights. Founded in 2024 and headquartered in Boston, US, Quilt Health, Inc. specializes in enhancing healthcare delivery for complex conditions.

The company has successfully completed its first funding round, raising USD 6. 00 mn in Seed funding on June 17, 2025. This round was co-led by MaC Venture Capital and Underscore VC, with participation from additional investors including BoxGroup and Coalition Operators. The founder's prior ventures are not publicly detailed, and there is no mention of any subsidiaries or parent companies.

Quilt Health primarily focuses on offering a digital health platform designed to improve care for individuals living with complex conditions, specifically targeting sickle cell disease. The platform connects patients with healthcare providers, treatment opportunities, and clinical trials, enhancing the patient experience by facilitating coordination of care among multi-disciplinary teams of clinicians and researchers. By integrating advanced data analytics and artificial intelligence, Quilt Health aims to provide personalized insights that empower patients and their care teams. Their services are designed to address gaps in access to quality care, aiming to reduce disparities and improve health outcomes.

Quilt Health operates in several geographical markets, including the United States and select regions in Europe, serving a diverse clientele that includes healthcare providers, research institutions, and patients. Quilt Health generates revenue through a subscription model tailored for healthcare organizations and institutions. By partnering with hospitals and clinics, the company facilitates access to its platform, allowing these entities to offer enhanced care coordination and patient engagement services. Transactions typically involve monthly or annual subscription fees, which grant access to the platform's features, including patient insights and engagement tools.

The company’s flagship services, which are critical for its business model, are designed to streamline the care process and improve treatment adherence among patients. Furthermore, Quilt Health may engage in partnerships that extend its reach and influence within the healthcare ecosystem, reinforcing its commitment to delivering innovative solutions for complex medical conditions. In June 2025, Quilt Health, Inc. raised USD 6.

00 mn in Seed funding to facilitate the expansion of its clinical trial recruitment platform and develop a patient access network. The company is focusing on launching new products in the upcoming year to enhance user experience and functionality. Additionally, Quilt Health is exploring opportunities to expand its services into new markets, targeting specific regions in Europe by late 2026. This strategic growth is supported by the recent funding, which will be allocated towards product development and market penetration efforts.